Patient | Age | Gender | Primary Site | Stage (UICC§ 2002) | Tumor Response (RECIST*) | Grade 3 or more Toxicities (CTCAE†v3.0) | Observation Period (months) |
---|---|---|---|---|---|---|---|
1 | 43 | M | base of tongue | cT4aN0M0 | PR | none | 25.9 |
2 | 70 | M | ethmoid sinus | cT4aN0M0 | PR | Grade 4 retinopathy | 20.9 |
3 | 62 | F | parotid grand | postoperative recurrence (pT3N0M0, R0) | CR | none | 14.0 |
4 | 37 | F | parotid grand | cT3N1M0 | PR | none | 49.6 |
5 | 81 | M | parotid grand | cT4aN0M0 | SD | none | 51.3 |
6 | 55 | M | parotid grand | postoperative residual (pT4aN0M0, R2) | CR | none | 31.3 |